News

Global-e's Upcoming Conferences: A Spotlight on Innovation

Global-e's Upcoming Conferences: A Spotlight on Innovation

Global-e’s Participation in Key Investor Conferences

Global-e (Nasdaq: GLBE), a trailblazer in the global direct-to-consumer e-commerce space, is geared up for an exciting December, indicated by its recent announcement regarding participation in notable investor conferences. These events reflect the company’s commitment to connecting with investors and sharing insights about their innovative platform.

UBS Global Technology and AI Conference

Scheduled for December, Global-e’s leadership team will engage actively at the UBS Global Technology and AI Conference. This event is particularly significant as it showcases cutting-edge advancements in technology that drive e-commerce forward.

Meet the Leaders

On December 2 and 3, 2025, Amir Schlachet, the Co-Founder and CEO of Global-e, alongside Ofer Koren, the CFO, and Alan Katz, the Vice President of Investor Relations, will participate in various investor meetings, culminating in an engaging fireside chat.

Fireside Chat Details

The fireside chat is set for December 3 at 9:35 AM ET. For those interested, the event will be webcast live, and a replay will be made available on the company’s Investor Relations website, ensuring that interested parties can stay informed about the discussion despite their location.

Raymond James TMT and Consumer Conference

Further solidifying its presence in the investor community, Global-e will also take part in the Raymond James TMT and Consumer Conference on December 8, 2025. Here, Alan Katz will represent the company, emphasizing the brand’s commitment to innovation and investor engagement.

Continuing Conversations

This conference allows Global-e to continue discussions with investors about its growth trajectory and market strategies. Such engagements are vital for sharing updates on the company’s performance and revealing future directions.

About Global-e

Global-e stands out as the world’s leading platform for enabling and accelerating global direct-to-consumer e-commerce. Partnering with over 1,400 brands and retailers across diverse markets including North America, EMEA, and APAC, Global-e simplifies international selling, making it as straightforward as selling domestically. By offering a seamless and localized shopping experience for online shoppers in more than 200 locations worldwide, the platform enhances merchants’ ability to convert international traffic into sales.

Comprehensive E-commerce Solutions

The company’s end-to-end e-commerce solutions include world-class localization capabilities, robust big-data analytics, and streamlined logistics operations. This ensures that international shoppers can buy effortlessly online while enabling retailers to expand their reach globally. Global-e’s vast experience in e-commerce positions it as a stalwart in enhancing cross-border shopping experiences.

Contact Information

Global-e Media Contact
Sarah Schloss
Email: sarah.schloss@headline.media
Phone: +1 914 506 5104

Global-e Investor Contact
Alan Katz
Vice President, Investor Relations
Email: IR@global-e.com

Frequently Asked Questions

What is Global-e's primary focus?

Global-e specializes in enabling direct-to-consumer e-commerce through its advanced platform, facilitating international sales for brands.

When will the UBS conference take place?

The UBS Global Technology and AI Conference is scheduled for December 2 and 3, 2025.

Who from Global-e will be attending the Raymond James conference?

Alan Katz, the Vice President of Investor Relations, will represent Global-e at the Raymond James TMT and Consumer Conference on December 8, 2025.

Where can I find the webcast of the fireside chat?

The webcast and replay of the UBS fireside chat will be available in the “News & Events” section of Global-e’s Investor Relations website when the event concludes.

How does Global-e enhance international e-commerce?

Global-e streamlines the international shopping experience by providing localized solutions and robust logistical support to facilitate cross-border transactions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 0

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 197

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 173

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

BerGenBio Welcomes First Patient in Lung Cancer Study

Updated Category News Views 202

BerGenBio Embarks on Promising Lung Cancer Trial BerGenBio ASA, a clinical-stage biopharmaceutical company dedicated to combating serious diseases through innovative therapies, has reached a significant milestone in its journey. The company has successfully included the first patient in its clinical trial, focusing on the cutting-edge AXL kinase inhibitor known as...

Continue Reading
CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform

Updated Category News Views 247

CIMG Inc. Introduces Tokenized Stock on FlowStocks Platform CIMG Inc. (NASDAQ: IMG), a dynamic group in the digital health and sales development sector, has officially launched its tokenized stock on the FlowStocks platform. This exciting development follows successful testing and represents a significant shift in how the company interacts with its investors. The new...

Continue Reading
Exploring the Impact of New SEC Leadership on Cryptocurrency

Updated Category News Views 179

New Era for Cryptocurrency Under SEC Leadership The recent changes at the Securities and Exchange Commission (SEC) under new leadership signal a transformative period for the cryptocurrency market. These developments could reshape the regulatory landscape, offering clarity and direction for investors and companies involved in the digital asset space. Understanding the...

Continue Reading
Shytoshi Kusama Transitions Roles: Shiba Inu's New Direction

Updated Category News Views 190

Shytoshi Kusama Transitions to New Leadership Role Shytoshi Kusama, the driving force behind the Shiba Inu ecosystem, has made a significant change by stepping down from his role as the lead visionary. This pivotal shift marks a transition to the position of lead ambassador, as he aims to spearhead global adoption more effectively. The Shift in Leadership Announcing his...

Continue Reading
BASF Shares Fall Following Proposed Dividend Cuts to Shareholders

Updated Category News Views 281

BASF (ETR:BASFN) just took a hit on its stock price after announcing some major shifts in its dividend policy. Shares plummeted by 2.9% to €44.035, all thanks to the company's new proposed minimum annual dividend of €2.25 per share for the upcoming 2024 business year. That’s a stark drop from the previous €3.40 per share they dished out in 2023—talk about making...

Continue Reading